VitaRost is a taxifolin-based ingredient, supported by an in-house clinical trial on vascular endothelial function (FMD), which has been completed and is currently being prepared for publication. In collaboration with multiple universities, it offers wide-ranging potential from health maintenance to disease prevention — a future-oriented functional ingredient that supports vascular health.